US · biotech · drug discovery · healthcare
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series D · Feb 2025 · $351M
Lux Capital, Alexandria Venture Investments
Reported by Crunchbase News · SEC filing: $351M sold under the offering, first sale Feb 2025
Missing a round, or an investor who was in one? Tell us.